Black Rock Inc. Akero Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,586,637 shares of AKRO stock, worth $252 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,586,637
Previous 4,892,616
14.19%
Holding current value
$252 Million
Previous $124 Million
6.05%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AKRO
# of Institutions
209Shares Held
66.9MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$309 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$272 Million0.09% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$236 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$195 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.7MShares$167 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...